Synergistic Growth Inhibition by Sorafenib and Cisplatin in Human Osteosarcoma Cells

Oncology Reports - Greece
doi 10.3892/or.2015.3832
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Inhibition of Autophagy Enhances Cisplatin-Induced Apoptosis in the MG63 Human Osteosarcoma Cell Line

Oncology Letters
Cancer ResearchOncology
2015English

Synergistic Interaction Between Cisplatin and Taxol in Human Ovarian Carcinoma Cells in Vitro

British Journal of Cancer
Cancer ResearchOncology
1994English

Enhancement of the Growth of Human Osteosarcoma Cells by Human Interferon-.Gamma..

Cell Structure and Function
MedicineCell BiologyMolecular BiologyPhysiology
1992English

MicroRNA-221 Promotes Cisplatin Resistance in Osteosarcoma Cells by Targeting PPP2R2A

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Synergistic Enhancement of Paclitaxel-Induced Inhibition of Cell Growth by Metformin in Melanoma Cells

Development & Reproduction
2019English

Base Excision Repair Inhibition by Methoxyamine Impairs Growth and Sensitizes Osteosarcoma Cells to Conventional Treatments

Journal of Cancer Therapy
2014English

Growth Inhibition of Combined Treatment of Cationic Liposome/P53 Complexes and Cisplatin on Human Carcinoma Cells

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2020English

Suppression of Heat Shock Protein 70 by siRNA Enhances the Antitumor Effects of Cisplatin in Cultured Human Osteosarcoma Cells

Cell Stress and Chaperones
BiochemistryCell Biology
2017English

Synergistic Antitumor Activity of Sorafenib in Combination With Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy